Why only 1 in 5 denied Medicare cancer drug appeals are overturned

August 17, 2026

1. UNMC names oncology, hematology chiefs Full story

2. FDA approves new class of multiple myeloma drug Full story

3. Every infusion appointment is a staffing decision. How leading systems are rethinking capacity in a constrained workforce era, here.

 

4. 85 cancer center leadership moves in 2026 Full story

5. Confluence Health $60M cancer center clears hurdle Full story

6. Newborn screening could flag cancer risk: 3 notes Full story

 

7. WVU Medicine hospital adds cancer leader Full story

8. Cancer surgery wait times keep growing: 5 notes Full story

9. Nationwide program to quit smoking would save US $12B: Study Full story

10. 1 in 5 denied Medicare cancer drug appeals overturned Full story

 

Becker’s Learning Opportunities

11. Longer, more complex cancer treatment journeys demand support between visits. Learn scalable models here.

12. A cancer misdiagnosis caught early saved one plan $174,000. See how here.

13. Duke’s oncology chief + WVU Medicine’s pharmacy chief on which pharma bets scale here.

14. Interested in more? See Becker’s full lineup of webinars and whitepapers.

 

 
 
 

 

Contact Us, Feedback, or Questions – Email ldyrda@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker’s Hospital Review, A Becker’s Healthcare Publication